IP Library Granted Patent US 10,568,993
Granted Patent B2
US 10,568,993 · App. 15/440,824 · Granted Feb 25, 2020

Fixation devices for tissue repair

Inventors: Nicholas J. Cotton (Westborough, MA); Emma J. Wright (Arlington, MA); Steven W. Astorino (Norfolk, MA); Saad Abdul Majeed Ali (York, GB)
Assignee: Smith & Nephew, Inc.
A61L31/16A61L31/048A61L31/06A61L31/129A61L2300/21A61L2300/412A61L2300/414A61L2300/42A61L2430/06A61L2430/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,568,993
App. No.
15/440,824
Granted
Feb 25, 2020
Kind
B2
Abstract

Fixation devices for tissue repair, for example sutures, surgical arrows, staples, darts, bolts, screws, buttons, anchors, nails, rivets, or barbed devices comprise at least one of angiogenic material; angiogenic precursor material which is capable of breaking down in vivo to form angiogenic material; or tissue-engineered material, which tissue-engineered material is capable of producing angiogenic material. In a preferred form, the material is incorporated into a polymer matrix having predetermined hydrophobicity to allow controlled release of angiogenic materials such as butyric or hydroxybutyric acid or salts thereof. Polymer matrix compositions comprising angiogenic materials and methods for tissue repair are also provided.

Claims (3)

1. A method of treatment of a tissue defect, comprising the step of implanting a fixation device into the tissue defect, the fixation device comprising a suture including three end USP size 6-0 polypropylene monofilaments intertwined with ultra-high molecular weight polyethylene filaments, wherein the polypropylene monofilaments comprise an angiogenic material in admixture with the polypropylene, wherein the angiogenic material is sodium butyrate and the monofilaments comprise 5% w/w of the sodium butyrate.

2. The method of claim 1 , wherein the tissue into which the fixation device is implanted is avascular tissue.

3. The method according to claim 1 , wherein the tissue is meniscus, articular cartilage, ligament, tendon, bone, or ischaemic tissue.

Continuity (3)
Division 12484274 · Jun 15, 2009
Provisional Application 61061317 · Jun 13, 2008
Related Publication 20170157302A1 · Jun 8, 2017